<?xml version="1.0" encoding="utf-8"?> <feed xmlns:dc="http://dublincore.org/documents/dcmi-namespace/" xmlns:media="http://search.yahoo.com/mrss/" xmlns="http://www.w3.org/2005/Atom"> <title type="text">McCarthy Tétrault LLP/S.E.N.C.R.L., s.r.l. - Montréal</title> <subtitle type="text">Contains the last 20 releases</subtitle> <id>uuid:87391d00-70ab-418a-987e-b09b7822934f;id=43576</id> <rights type="text">Copyright 2017, McCarthy Tétrault LLP/S.E.N.C.R.L., s.r.l. - Montréal</rights> <updated>2017-10-11T12:00:00Z</updated> <author> <name>newsdesk@globenewswire.com (NewsDesk)</name> <uri>http://www.globenewswire.com/LegacyRss?Length=4</uri> <email>newsdesk@globenewswire.com</email> </author> <link rel="alternate" href="https://www.globenewswire.com/atomfeed/organization/Xi7TduYUeYXh6hlWgXjWtw==" /> <link rel="self" href="https://www.globenewswire.com/atomfeed/organization/Xi7TduYUeYXh6hlWgXjWtw==" /> <entry> <id>https://www.globenewswire.com/news-release/2017/10/11/1160803/0/en/Champion-Announces-Entering-Into-Definitive-Agreements-for-Previously-Announced-Financing-Arrangements.html</id> <title type="text">Champion Announces Entering Into Definitive Agreements for Previously Announced Financing Arrangements</title> <published>2017-10-11T12:00:00Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/10/11/1160803/0/en/Champion-Announces-Entering-Into-Definitive-Agreements-for-Previously-Announced-Financing-Arrangements.html" /> <content type="html"><![CDATA[<p><strong>MONTRÉAL, QUÉBEC--(Marketwired - Oct. 11, 2017) -</strong> </p>]]></content> <dc:identifier>1160803</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Champion Iron Limited</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:59 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/10/11/1160805/0/fr/Champion-annonce-la-conclusion-d-ententes-d%C3%A9finitives-%C3%A0-l-%C3%A9gard-de-ses-ententes-de-financement-d%C3%A9j%C3%A0-annonc%C3%A9es.html</id> <title type="text">Champion annonce la conclusion d'ententes définitives à l'égard de ses ententes de financement déjà annoncées</title> <published>2017-10-11T12:00:00Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/10/11/1160805/0/fr/Champion-annonce-la-conclusion-d-ententes-d%C3%A9finitives-%C3%A0-l-%C3%A9gard-de-ses-ententes-de-financement-d%C3%A9j%C3%A0-annonc%C3%A9es.html" /> <content type="html"><![CDATA[<p><strong>MONTRÉAL, QUÉBEC--(Marketwired - 11 oct. 2017) -</strong> </p>]]></content> <dc:identifier>1160805</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Champion Iron Limited</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:59 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/09/15/1160801/0/en/Canada-House-Wellness-Group-Announces-Issuance-of-Management-Cease-Trade-Order.html</id> <title type="text">Canada House Wellness Group Announces Issuance of Management Cease Trade Order</title> <published>2017-09-15T12:30:00Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/09/15/1160801/0/en/Canada-House-Wellness-Group-Announces-Issuance-of-Management-Cease-Trade-Order.html" /> <content type="html"><![CDATA[<p><strong>TORONTO, ONTARIO--(Marketwired - Sept. 15, 2017) -</strong> </p>]]></content> <dc:identifier>1160801</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Canada House Wellness Group Inc.</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:59 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/09/05/1160800/0/en/All-Three-Canada-House-Wholly-Owned-Subsidiaries-Have-Recently-Reached-Important-Goals.html</id> <title type="text">All Three Canada House Wholly Owned Subsidiaries Have Recently Reached Important Goals</title> <published>2017-09-05T12:00:00Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/09/05/1160800/0/en/All-Three-Canada-House-Wholly-Owned-Subsidiaries-Have-Recently-Reached-Important-Goals.html" /> <content type="html"><![CDATA[<p><strong>TORONTO, ONTARIO--(Marketwired - Sept. 5, 2017) -</strong> Canada House Wellness Group Inc. (CSE:CHV)(CSE:CHV.CN)(CNSX:CHV) ("<strong>Canada House</strong>" or the "<strong>Company</strong>") is pleased to announce that all three of its wholly-owned subsidiaries, Marijuana for Trauma "MFT", Knalysis Technologies "Knalysis" and Abba Medix "Abba", have reached important goals.</p>]]></content> <dc:identifier>1160800</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Canada House Wellness Group Inc.</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:59 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/08/28/1160797/0/fr/Champion-Iron-annonce-un-financement-de-25-millions-de-dollars-US-et-des-ententes-off-take-avec-Glencore-dans-le-cadre-de-la-relance-de-la-mine-du-lac-Bloom.html</id> <title type="text">Champion Iron annonce un financement de 25 millions de dollars US et des ententes "off-take" avec Glencore dans le cadre de la relance de la mine du lac Bloom...</title> <published>2017-08-28T23:47:41Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/08/28/1160797/0/fr/Champion-Iron-annonce-un-financement-de-25-millions-de-dollars-US-et-des-ententes-off-take-avec-Glencore-dans-le-cadre-de-la-relance-de-la-mine-du-lac-Bloom.html" /> <content type="html"><![CDATA[<p><em><p>...et fait le point sur son placement par voie de prospectus</p></em></p><p><strong>MONTRÉAL, QUÉBEC--(Marketwired - 28 août 2017) -</strong> </p>]]></content> <dc:identifier>1160797</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Champion Iron Limited</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:59 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/08/28/1160796/0/en/Champion-Iron-Announces-US-25-Million-Financing-and-Off-Take-Arrangements-with-Glencore-in-Connection-with-the-Bloom-Lake-Mine-Restart-and-Provides-an-Update-on-its-Prospectus-Offe.html</id> <title type="text">Champion Iron Announces US$25 Million Financing and Off-Take Arrangements with Glencore in Connection with the Bloom Lake Mine Restart and Provides an Update on its Prospectus Offering</title> <published>2017-08-28T23:47:11Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/08/28/1160796/0/en/Champion-Iron-Announces-US-25-Million-Financing-and-Off-Take-Arrangements-with-Glencore-in-Connection-with-the-Bloom-Lake-Mine-Restart-and-Provides-an-Update-on-its-Prospectus-Offe.html" /> <content type="html"><![CDATA[<p><strong>MONTRÉAL, QUÉBEC--(Marketwired - Aug. 28, 2017) -</strong> </p>]]></content> <dc:identifier>1160796</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Champion Iron Limited</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:59 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/07/25/1160793/0/en/Partners-Confirms-Initial-Partial-Redemption-of-Its-Series-II-Debentures-Will-Occur-on-July-31.html</id> <title type="text">Partners Confirms Initial Partial Redemption of Its Series II Debentures Will Occur on July 31</title> <published>2017-07-25T13:42:36Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/07/25/1160793/0/en/Partners-Confirms-Initial-Partial-Redemption-of-Its-Series-II-Debentures-Will-Occur-on-July-31.html" /> <content type="html"><![CDATA[<p><strong>TORONTO, ONTARIO--(Marketwired - July 25, 2017) -</strong> On June 30, 2017, Partners Real Estate Investment Trust (the "REIT," or "Partners") (TSX:PAR.UN) announced its intention to partially redeem its outstanding Series II 6.0% Convertible Unsecured Subordinated Debentures due September 30, 2017 (TSX:PAR.DB.A) ("Series II Debentures"). The REIT confirms that on the date of redemption, July 31, 2017, 50% of the principal amount of Series II Debentures outstanding will be redeemed, on a pro rata basis, upon payment of a redemption amount of $1,020.054795 for each $1,000 principal amount of Series II Debentures, being equal to the aggregate of $1,000 and all accrued and unpaid interest hereon to but excluding the redemption date.</p>]]></content> <dc:identifier>1160793</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Partners Real Estate Investment Trust</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:59 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/07/14/1160792/0/en/Jamieson-Wellness-Inc-Announces-Closing-of-the-Underwriters-Over-Allotment-Option.html</id> <title type="text">Jamieson Wellness Inc. Announces Closing of the Underwriters' Over-Allotment Option</title> <published>2017-07-14T13:00:00Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/07/14/1160792/0/en/Jamieson-Wellness-Inc-Announces-Closing-of-the-Underwriters-Over-Allotment-Option.html" /> <content type="html"><![CDATA[<p style="vertical-align: baseline;"><strong> TORONTO, ONTARIO--(Marketwired - July 14, 2017) -</strong> </p>]]></content> <dc:identifier>1160792</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Jamieson Wellness Inc.</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:59 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/07/11/1160789/0/en/Advanced-Proteome-Therapeutics-Corporation-Completes-Rights-Offering-for-Gross-Proceeds-of-Approximately-430-000.html</id> <title type="text">Advanced Proteome Therapeutics Corporation Completes Rights Offering for Gross Proceeds of Approximately $430,000</title> <published>2017-07-11T14:51:29Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/07/11/1160789/0/en/Advanced-Proteome-Therapeutics-Corporation-Completes-Rights-Offering-for-Gross-Proceeds-of-Approximately-430-000.html" /> <content type="html"><![CDATA[<p style="vertical-align: baseline;"><strong>VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 11, 2017) -</strong> Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE:APC)(FRANKFURT:0E8) is pleased to report that it has completed its previously announced rights offering (the "Rights Offering"). </p>]]></content> <dc:identifier>1160789</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Advanced Proteome Therapeutics Corporation</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:59 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/06/27/1160787/0/en/David-Brereton-and-Kathryn-Ensign-Brereton-dispose-of-Tecsys-shares-pursuant-to-a-secondary-offering.html</id> <title type="text">David Brereton and Kathryn Ensign-Brereton dispose of Tecsys shares pursuant to a secondary offering</title> <published>2017-06-27T21:15:00Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/06/27/1160787/0/en/David-Brereton-and-Kathryn-Ensign-Brereton-dispose-of-Tecsys-shares-pursuant-to-a-secondary-offering.html" /> <content type="html"><![CDATA[<p style="vertical-align: baseline;"><strong>MONTRÉAL, QUÉBEC--(Marketwired - June 27, 2017) -</strong> On June 27, David Brereton, Executive Chairman of TECSYS Inc. ("<strong>TECSYS</strong>") and Kathryn Ensign-Brereton, his spouse, disposed of an aggregate of 333,000 common shares ("<strong>Shares</strong>") of TECSYS at a price of $15.00 per Share pursuant to a previously announced bought-deal secondary offering of Shares (the "<strong>Secondary Offering</strong>") qualified under a short form prospectus dated June 19, 2017 ("<strong>Prospectus</strong>"). </p>]]></content> <dc:identifier>1160787</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>David Brereton and Kathryn Ensign-Brereton</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:59 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/06/27/1160786/0/en/Canada-House-Negotiates-New-10-Year-Lease-for-Abba-Medix-Grow-Facility.html</id> <title type="text">Canada House Negotiates New 10-Year Lease for Abba Medix Grow Facility</title> <published>2017-06-27T13:41:44Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/06/27/1160786/0/en/Canada-House-Negotiates-New-10-Year-Lease-for-Abba-Medix-Grow-Facility.html" /> <content type="html"><![CDATA[<p><strong>TORONTO, ONTARIO--(Marketwired - June 27, 2017) -</strong> <strong>Canada House Wellness Group Inc. "Canada House" (CSE:CHV)(CSE:CHV.CN)(CNSX:CHV)</strong>, together with its three operating divisions, Marijuana For Trauma "MFT", Knalysis Technologies "KT" and Abba Medix "Abba" is pleased to announce that it has negotiated a new extended lease for Abba's grow facility.</p>]]></content> <dc:identifier>1160786</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Canada House Wellness Group Inc.</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:59 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/06/21/1160783/0/en/Enablence-Technologies-Provides-an-Update-on-Financings.html</id> <title type="text">Enablence Technologies Provides an Update on Financings</title> <published>2017-06-21T12:30:00Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/06/21/1160783/0/en/Enablence-Technologies-Provides-an-Update-on-Financings.html" /> <content type="html"><![CDATA[<p><strong>OTTAWA, ONTARIO--(Marketwired - June 21, 2017) -</strong> </p>]]></content> <dc:identifier>1160783</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Enablence Technologies Inc.</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:59 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/06/01/1160781/0/en/Advanced-Proteome-Therapeutics-Corporation-Announces-Rights-Offering.html</id> <title type="text">Advanced Proteome Therapeutics Corporation Announces Rights Offering</title> <published>2017-06-01T12:30:00Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/06/01/1160781/0/en/Advanced-Proteome-Therapeutics-Corporation-Announces-Rights-Offering.html" /> <content type="html"><![CDATA[<p style="vertical-align: baseline;"><strong>VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 1, 2017) -</strong> Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE:APC)(FRANKFURT:0E8) is pleased to announce that it will conduct a rights offering to raise gross proceeds of up to $1,900,281 (the "Rights Offering").</p>]]></content> <dc:identifier>1160781</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Advanced Proteome Therapeutics Corporation</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:59 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/04/10/1160779/0/en/Advanced-Proteome-Therapeutics-Corporation-Announces-Bridge-Loan-Financing.html</id> <title type="text">Advanced Proteome Therapeutics Corporation Announces Bridge Loan Financing</title> <published>2017-04-10T18:30:20Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/04/10/1160779/0/en/Advanced-Proteome-Therapeutics-Corporation-Announces-Bridge-Loan-Financing.html" /> <content type="html"><![CDATA[<p style="vertical-align: baseline;"><strong>VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 10, 2017) -</strong> Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE:APC)(FRANKFURT:0E8) announces that it has entered into loan agreements with three lenders for loans in the aggregate amount of $250,000 (the "Loans"). The Loans bear interest at an annual rate of 12% and will be repayable in full on April 7, 2018. In addition, the Company may prepay all or a portion of the Loans in advance at any time without penalty. </p>]]></content> <dc:identifier>1160779</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Advanced Proteome Therapeutics Corporation</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:58 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/04/05/1160777/0/en/Enablence-Technologies-Announces-Additional-Financings.html</id> <title type="text">Enablence Technologies Announces Additional Financings</title> <published>2017-04-05T23:30:00Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/04/05/1160777/0/en/Enablence-Technologies-Announces-Additional-Financings.html" /> <content type="html"><![CDATA[<p><em><p>Enablence also Announces Termination of Previously Announced Letter of Intent with Esrey Energy Ltd.</p></em></p><p><strong>OTTAWA, ONTARIO--(Marketwired - April 5, 2017) -</strong> Enablence Technologies Inc. ("Enablence" or the "Company") (TSX VENTURE:ENA), a leading supplier of optical components and subsystems for access, metro and long-haul markets, today announces its intention to complete additional financings for approximately $6 million. </p>]]></content> <dc:identifier>1160777</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Enablence Technologies Inc.</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:58 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/12/08/1160776/0/en/Enablence-Technologies-announces-a-non-brokered-private-placement-and-signing-of-a-non-binding-Letter-of-Intent-with-Esrey-Energy.html</id> <title type="text">Enablence Technologies announces a non-brokered private placement and signing of a non-binding Letter of Intent with Esrey Energy</title> <published>2016-12-08T18:15:45Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/12/08/1160776/0/en/Enablence-Technologies-announces-a-non-brokered-private-placement-and-signing-of-a-non-binding-Letter-of-Intent-with-Esrey-Energy.html" /> <content type="html"><![CDATA[<p><strong>OTTAWA, ONTARIO--(Marketwired - Dec. 8, 2016) -</strong> Enablence Technologies Inc. ("<strong>Enablence</strong>" or the "<strong>Company</strong>") (TSX VENTURE:ENA), a leading supplier of optical components and subsystems for telecommunication and data centre markets today announced a non-brokered private placement financing (the "<strong>Financing</strong>") for up to 50,000,000 common shares (the "<strong>Shares</strong>") at a price of $0.08 per share (the "<strong>Issue Price</strong>"), subject to TSX Venture Exchange approval.</p>]]></content> <dc:identifier>1160776</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Enablence Technologies Inc.</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:58 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/12/06/1160774/0/en/Polygon-Mining-Opportunity-Master-Fund-Updates-Early-Warning-Report-for-Caza-Gold-Corp.html</id> <title type="text">Polygon Mining Opportunity Master Fund Updates Early Warning Report for Caza Gold Corp.</title> <published>2016-12-06T13:10:45Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/12/06/1160774/0/en/Polygon-Mining-Opportunity-Master-Fund-Updates-Early-Warning-Report-for-Caza-Gold-Corp.html" /> <content type="html"><![CDATA[<p><strong>NEW YORK CITY, NEW YORK--(Marketwired - Dec. 6, 2016) -</strong> Polygon Mining Opportunity Master Fund ("<strong>Polygon</strong>") announces that on December 5, 2016, it entered into a lock-up agreement (the "<strong>Lock-up Agreement</strong>") with Royal Road Minerals Limited (the "<strong>Offeror</strong>") pursuant to which Polygon agreed to deposit the common shares that it owns in the capital of Caza Gold Corp. ("<strong>Caza</strong>") to a take-over bid to be made by the Offeror in accordance with a support agreement entered into between the Offeror and Caza (the "<strong>Support Agreement</strong>"). Pursuant to the Support Agreement, the Offeror will offer 0.16 of an ordinary share of the Offeror for each common share of Caza, subject to the satisfaction of certain conditions. The Lock-up Agreement can be terminated by Polygon in certain circumstances. </p>]]></content> <dc:identifier>1160774</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Polygon Mining Opportunity Master Fund</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:58 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/11/16/1160771/0/en/BDC-Capital-Inc-acquires-Common-shares-in-Profound-Medical-Corp.html</id> <title type="text">BDC Capital Inc. acquires Common shares in Profound Medical Corp.</title> <published>2016-11-16T21:30:00Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/11/16/1160771/0/en/BDC-Capital-Inc-acquires-Common-shares-in-Profound-Medical-Corp.html" /> <content type="html"><![CDATA[<p style="vertical-align: baseline;"><strong>MONTRÉAL, QUÉBEC--(Marketwired - Nov. 16, 2016) -</strong> On November 14, 2016, BDC Capital Inc. ("<strong>BDC Capital</strong>"), a wholly-owned subsidiary of the Business Development Bank of Canada (the "<strong>BDC</strong>"), purchased 3,636,363 common shares (the "<strong>Common Shares</strong>") in the capital of Profound Medical Corp. ("<strong>Profound Medical</strong>") at a price of $1.10 per Common Share pursuant to a public offering (the "<strong>Offering</strong>") of Common Shares (representing approximately 6.6% of the issued and outstanding Common Shares after giving effect to the Offering). </p>]]></content> <dc:identifier>1160771</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>BDC Capital Inc.</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:58 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/10/07/1160770/0/en/Northquest-Ltd-Receives-the-Final-Order-Approving-the-Plan-of-Arrangement-Involving-Nord-Gold-SE.html</id> <title type="text">Northquest Ltd. Receives the Final Order Approving the Plan of Arrangement Involving Nord Gold SE</title> <published>2016-10-07T15:17:27Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/10/07/1160770/0/en/Northquest-Ltd-Receives-the-Final-Order-Approving-the-Plan-of-Arrangement-Involving-Nord-Gold-SE.html" /> <content type="html"><![CDATA[<p><strong>TORONTO, ONTARIO--(Marketwired - Oct. 7, 2016) -</strong> Northquest Ltd. (TSX VENTURE:NQ)(FRANKFURT:N3Q) (the "<strong>Company</strong>") is pleased to announce that the Ontario Superior Court of Justice has granted its final order approving the previously announced statutory plan of arrangement (the "<strong>Arrangement</strong>") under the <em>Business Corporations Act</em> (Ontario), whereby Nord Gold SE ("<strong>Nordgold</strong>") will acquire all of the outstanding common shares of the Company (the "<strong>Shares</strong>") that it did not already own. At a special meeting held on September 28, 2016, the Arrangement was approved by the shareholders of the Company. It is expected that the Arrangement will be completed in the coming days.</p>]]></content> <dc:identifier>1160770</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Northquest Ltd.</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:58 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/10/06/1160768/0/fr/Groupe-Gestion-G5-souscrit-%C3%A0-une-d%C3%A9benture-convertible-d-AtmanCo.html</id> <title type="text">Groupe Gestion G5 souscrit à une débenture convertible d'AtmanCo</title> <published>2016-10-06T13:43:42Z</published> <updated>2024-11-26T16:11:09Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/10/06/1160768/0/fr/Groupe-Gestion-G5-souscrit-%C3%A0-une-d%C3%A9benture-convertible-d-AtmanCo.html" /> <content type="html"><![CDATA[<p><strong>BELOEIL, QUÉBEC--(Marketwired - 6 oct. 2016) -</strong> Dans le cadre d'un placement privé (le « <strong>Placement privé</strong> »), Groupe Gestion G5 Inc. (« <strong>Gestion G5</strong> »), une société de portefeuille constituée en vertu des lois du Québec, a acquis, en date du 5 octobre 2016, pour une contrepartie totale de 2 000 000 $, une débenture convertible d'AtmanCo Inc. (« <strong>AtmanCo</strong> ») au montant de 2 000 000 $ (la « <strong>Débenture</strong> »), le capital de laquelle est convertible, jusqu'au 1<sup>er</sup> anniversaire de son émission, en un maximum de 23 529 411 actions ordinaires dans le capital d'AtmanCo (les « <strong>Actions ordinaires</strong> ») à un prix de conversion de 0,085 $ par Action ordinaire et par la suite, jusqu'au 5 octobre 2021, en un maximum de 20 000 000 Actions ordinaires à un prix de conversion de 0,10 $ par Action ordinaire. </p>]]></content> <dc:identifier>1160768</dc:identifier> <dc:language>fr</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Groupe Gestion G5 Inc.</dc:contributor> <dc:modified>Wed, 14 Feb 2018 01:58 GMT</dc:modified> </entry> </feed>